New York State Common Retirement Fund’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,110
Closed -$45.6K 3238
2025
Q2
$45.6K Hold
10,110
﹤0.01% 2966
2025
Q1
$44.8K Hold
10,110
﹤0.01% 2815
2024
Q4
$79.2K Hold
10,110
﹤0.01% 2688
2024
Q3
$133K Sell
10,110
-2,500
-20% -$31.7K ﹤0.01% 2469
2024
Q2
$152K Sell
12,610
-3
-0% -$41 ﹤0.01% 2551
2024
Q1
$205K Buy
12,613
+6,374
+102% +$85.9K ﹤0.01% 2426
2023
Q4
$42.5K Sell
6,239
-31
-0.5% -$179 ﹤0.01% 3037
2023
Q3
$34.2K Buy
6,270
+97
+2% +$565 ﹤0.01% 3108
2023
Q2
$41.9K Sell
6,173
-52
-0.8% -$390 ﹤0.01% 3164
2023
Q1
$31.2K Sell
6,225
-18,400
-75% -$75.1K ﹤0.01% 3067
2022
Q4
$120K Buy
24,625
+10
+0% +$73 ﹤0.01% 2907
2022
Q3
$355K Buy
24,615
+61
+0.2% +$1.01K ﹤0.01% 2506
2022
Q2
$372K Sell
24,554
-25
-0.1% -$292 ﹤0.01% 2500
2022
Q1
$292K Sell
24,579
-211,705
-90% -$2.17M ﹤0.01% 2658
2021
Q4
$3.83M Sell
236,284
-65,714
-22% -$1.4M ﹤0.01% 1428
2021
Q3
$8.62M Buy
301,998
+60,228
+25% +$1.9M 0.01% 1068
2021
Q2
$8.17M Buy
241,770
+3,243
+1% +$104K 0.01% 1110
2021
Q1
$7.21M Buy
238,527
+38,928
+20% +$1.6M 0.01% 1110
2020
Q4
$9.88M Buy
199,599
+49,619
+33% +$2.3M 0.01% 951
2020
Q3
$5.76M Buy
149,980
+23,202
+18% +$923K 0.01% 1110
2020
Q2
$5.48M Buy
126,778
+6,700
+6% +$253K 0.01% 1134
2020
Q1
$3.13M Buy
120,078
+99,278
+477% +$2.88M ﹤0.01% 1231
2019
Q4
$650K Hold
20,800
﹤0.01% 2159
2019
Q3
$542K Hold
20,800
﹤0.01% 2290
2019
Q2
$476K Buy
20,800
+18,400
+767% +$423K ﹤0.01% 2400
2019
Q1
$63K Buy
+2,400
New +$52.7K ﹤0.01% 3041

Other funds holding YMAB

New York State Common Retirement Fund's YMAB Position: Q3 2025 in Review

New York State Common Retirement Fund sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 10,110 shares — an estimated $45.6K sold.

New York State Common Retirement Fund first reported a position in YMAB in Q1 2019 and held it in 26 quarters. The position peaked at $9.88M in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • New York State Common Retirement Fund reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 10,110 Y-mAbs Therapeutics shares in Q3 2025, an estimated $45.6K.
  • New York State Common Retirement Fund first reported a position in Y-mAbs Therapeutics in Q1 2019 and held it in 26 quarters.
  • New York State Common Retirement Fund's Y-mAbs Therapeutics position peaked at $9.88M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.